Global Biologics Market Insights, Forecast to 2029

Global Biologics Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 Biologics Product Introduction
1.2 Market by Type
1.2.1 Global Biologics Market Size by Type, 2018 VS 2022 VS 2029
1.2.2 Monoclonal Antibodies
1.2.3 Vaccines
1.2.4 Recombinant Proteins
1.2.5 Antisense
1.2.6 RNAi
1.3 Market by Application
1.3.1 Global Biologics Market Size by Application, 2018 VS 2022 VS 2029
1.3.2 Infectious Diseases
1.3.3 Oncology
1.3.4 Immunology
1.3.5 Autoimmune Diseases
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Biologics Production
2.1 Global Biologics Production Capacity (2018-2029)
2.2 Global Biologics Production by Region: 2018 VS 2022 VS 2029
2.3 Global Biologics Production by Region
2.3.1 Global Biologics Historic Production by Region (2018-2023)
2.3.2 Global Biologics Forecasted Production by Region (2024-2029)
2.3.3 Global Biologics Production Market Share by Region (2018-2029)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Biologics Revenue Estimates and Forecasts 2018-2029
3.2 Global Biologics Revenue by Region
3.2.1 Global Biologics Revenue by Region: 2018 VS 2022 VS 2029
3.2.2 Global Biologics Revenue by Region (2018-2023)
3.2.3 Global Biologics Revenue by Region (2024-2029)
3.2.4 Global Biologics Revenue Market Share by Region (2018-2029)
3.3 Global Biologics Sales Estimates and Forecasts 2018-2029
3.4 Global Biologics Sales by Region
3.4.1 Global Biologics Sales by Region: 2018 VS 2022 VS 2029
3.4.2 Global Biologics Sales by Region (2018-2023)
3.4.3 Global Biologics Sales by Region (2024-2029)
3.4.4 Global Biologics Sales Market Share by Region (2018-2029)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Biologics Sales by Manufacturers
4.1.1 Global Biologics Sales by Manufacturers (2018-2023)
4.1.2 Global Biologics Sales Market Share by Manufacturers (2018-2023)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biologics in 2022
4.2 Global Biologics Revenue by Manufacturers
4.2.1 Global Biologics Revenue by Manufacturers (2018-2023)
4.2.2 Global Biologics Revenue Market Share by Manufacturers (2018-2023)
4.2.3 Global Top 10 and Top 5 Companies by Biologics Revenue in 2022
4.3 Global Biologics Sales Price by Manufacturers
4.4 Global Key Players of Biologics, Industry Ranking, 2021 VS 2022 VS 2023
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Biologics, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Biologics, Product Offered and Application
4.8 Global Key Manufacturers of Biologics, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Biologics Sales by Type
5.1.1 Global Biologics Historical Sales by Type (2018-2023)
5.1.2 Global Biologics Forecasted Sales by Type (2024-2029)
5.1.3 Global Biologics Sales Market Share by Type (2018-2029)
5.2 Global Biologics Revenue by Type
5.2.1 Global Biologics Historical Revenue by Type (2018-2023)
5.2.2 Global Biologics Forecasted Revenue by Type (2024-2029)
5.2.3 Global Biologics Revenue Market Share by Type (2018-2029)
5.3 Global Biologics Price by Type
5.3.1 Global Biologics Price by Type (2018-2023)
5.3.2 Global Biologics Price Forecast by Type (2024-2029)
6 Market Size by Application
6.1 Global Biologics Sales by Application
6.1.1 Global Biologics Historical Sales by Application (2018-2023)
6.1.2 Global Biologics Forecasted Sales by Application (2024-2029)
6.1.3 Global Biologics Sales Market Share by Application (2018-2029)
6.2 Global Biologics Revenue by Application
6.2.1 Global Biologics Historical Revenue by Application (2018-2023)
6.2.2 Global Biologics Forecasted Revenue by Application (2024-2029)
6.2.3 Global Biologics Revenue Market Share by Application (2018-2029)
6.3 Global Biologics Price by Application
6.3.1 Global Biologics Price by Application (2018-2023)
6.3.2 Global Biologics Price Forecast by Application (2024-2029)
7 US & Canada
7.1 US & Canada Biologics Market Size by Type
7.1.1 US & Canada Biologics Sales by Type (2018-2029)
7.1.2 US & Canada Biologics Revenue by Type (2018-2029)
7.2 US & Canada Biologics Market Size by Application
7.2.1 US & Canada Biologics Sales by Application (2018-2029)
7.2.2 US & Canada Biologics Revenue by Application (2018-2029)
7.3 US & Canada Biologics Sales by Country
7.3.1 US & Canada Biologics Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 US & Canada Biologics Sales by Country (2018-2029)
7.3.3 US & Canada Biologics Revenue by Country (2018-2029)
7.3.4 U.S.
7.3.5 Canada
8 Europe
8.1 Europe Biologics Market Size by Type
8.1.1 Europe Biologics Sales by Type (2018-2029)
8.1.2 Europe Biologics Revenue by Type (2018-2029)
8.2 Europe Biologics Market Size by Application
8.2.1 Europe Biologics Sales by Application (2018-2029)
8.2.2 Europe Biologics Revenue by Application (2018-2029)
8.3 Europe Biologics Sales by Country
8.3.1 Europe Biologics Revenue by Country: 2018 VS 2022 VS 2029
8.3.2 Europe Biologics Sales by Country (2018-2029)
8.3.3 Europe Biologics Revenue by Country (2018-2029)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Biologics Market Size by Type
9.1.1 China Biologics Sales by Type (2018-2029)
9.1.2 China Biologics Revenue by Type (2018-2029)
9.2 China Biologics Market Size by Application
9.2.1 China Biologics Sales by Application (2018-2029)
9.2.2 China Biologics Revenue by Application (2018-2029)
10 Asia (excluding China)
10.1 Asia Biologics Market Size by Type
10.1.1 Asia Biologics Sales by Type (2018-2029)
10.1.2 Asia Biologics Revenue by Type (2018-2029)
10.2 Asia Biologics Market Size by Application
10.2.1 Asia Biologics Sales by Application (2018-2029)
10.2.2 Asia Biologics Revenue by Application (2018-2029)
10.3 Asia Biologics Sales by Region
10.3.1 Asia Biologics Revenue by Region: 2018 VS 2022 VS 2029
10.3.2 Asia Biologics Revenue by Region (2018-2029)
10.3.3 Asia Biologics Sales by Region (2018-2029)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Biologics Market Size by Type
11.1.1 Middle East, Africa and Latin America Biologics Sales by Type (2018-2029)
11.1.2 Middle East, Africa and Latin America Biologics Revenue by Type (2018-2029)
11.2 Middle East, Africa and Latin America Biologics Market Size by Application
11.2.1 Middle East, Africa and Latin America Biologics Sales by Application (2018-2029)
11.2.2 Middle East, Africa and Latin America Biologics Revenue by Application (2018-2029)
11.3 Middle East, Africa and Latin America Biologics Sales by Country
11.3.1 Middle East, Africa and Latin America Biologics Revenue by Country: 2018 VS 2022 VS 2029
11.3.2 Middle East, Africa and Latin America Biologics Revenue by Country (2018-2029)
11.3.3 Middle East, Africa and Latin America Biologics Sales by Country (2018-2029)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 Eli Lilly & Company
12.1.1 Eli Lilly & Company Company Information
12.1.2 Eli Lilly & Company Overview
12.1.3 Eli Lilly & Company Biologics Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.1.4 Eli Lilly & Company Biologics Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Eli Lilly & Company Recent Developments
12.2 Samsung Biologics
12.2.1 Samsung Biologics Company Information
12.2.2 Samsung Biologics Overview
12.2.3 Samsung Biologics Biologics Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.2.4 Samsung Biologics Biologics Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Samsung Biologics Recent Developments
12.3 F Hoffman La Roche
12.3.1 F Hoffman La Roche Company Information
12.3.2 F Hoffman La Roche Overview
12.3.3 F Hoffman La Roche Biologics Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.3.4 F Hoffman La Roche Biologics Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 F Hoffman La Roche Recent Developments
12.4 Celltrion
12.4.1 Celltrion Company Information
12.4.2 Celltrion Overview
12.4.3 Celltrion Biologics Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.4.4 Celltrion Biologics Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Celltrion Recent Developments
12.5 Addgene
12.5.1 Addgene Company Information
12.5.2 Addgene Overview
12.5.3 Addgene Biologics Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.5.4 Addgene Biologics Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Addgene Recent Developments
12.6 Amgen
12.6.1 Amgen Company Information
12.6.2 Amgen Overview
12.6.3 Amgen Biologics Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.6.4 Amgen Biologics Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Amgen Recent Developments
12.7 Abbvie Inc.
12.7.1 Abbvie Inc. Company Information
12.7.2 Abbvie Inc. Overview
12.7.3 Abbvie Inc. Biologics Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.7.4 Abbvie Inc. Biologics Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Abbvie Inc. Recent Developments
12.8 Sanofi
12.8.1 Sanofi Company Information
12.8.2 Sanofi Overview
12.8.3 Sanofi Biologics Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.8.4 Sanofi Biologics Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Sanofi Recent Developments
12.9 Pfizer Inc.
12.9.1 Pfizer Inc. Company Information
12.9.2 Pfizer Inc. Overview
12.9.3 Pfizer Inc. Biologics Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.9.4 Pfizer Inc. Biologics Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Pfizer Inc. Recent Developments
12.10 Merck & Co. Inc.
12.10.1 Merck & Co. Inc. Company Information
12.10.2 Merck & Co. Inc. Overview
12.10.3 Merck & Co. Inc. Biologics Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.10.4 Merck & Co. Inc. Biologics Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Merck & Co. Inc. Recent Developments
12.11 Novo Nordisk A/S
12.11.1 Novo Nordisk A/S Company Information
12.11.2 Novo Nordisk A/S Overview
12.11.3 Novo Nordisk A/S Biologics Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.11.4 Novo Nordisk A/S Biologics Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Novo Nordisk A/S Recent Developments
12.12 Johnson & Johnson Services Inc.
12.12.1 Johnson & Johnson Services Inc. Company Information
12.12.2 Johnson & Johnson Services Inc. Overview
12.12.3 Johnson & Johnson Services Inc. Biologics Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.12.4 Johnson & Johnson Services Inc. Biologics Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Johnson & Johnson Services Inc. Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Biologics Industry Chain Analysis
13.2 Biologics Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Biologics Production Mode & Process
13.4 Biologics Sales and Marketing
13.4.1 Biologics Sales Channels
13.4.2 Biologics Distributors
13.5 Biologics Customers
14 Biologics Market Dynamics
14.1 Biologics Industry Trends
14.2 Biologics Market Drivers
14.3 Biologics Market Challenges
14.4 Biologics Market Restraints
15 Key Finding in The Global Biologics Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Biologics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Monoclonal Antibodies
Table 3. Major Manufacturers of Vaccines
Table 4. Major Manufacturers of Recombinant Proteins
Table 5. Major Manufacturers of Antisense
Table 6. Major Manufacturers of RNAi
Table 7. Global Biologics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Biologics Production by Region: 2018 VS 2022 VS 2029 (K MT)
Table 9. Global Biologics Production by Region (2018-2023) & (K MT)
Table 10. Global Biologics Production by Region (2024-2029) & (K MT)
Table 11. Global Biologics Production Market Share by Region (2018-2023)
Table 12. Global Biologics Production Market Share by Region (2024-2029)
Table 13. Global Biologics Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 14. Global Biologics Revenue by Region (2018-2023) & (US$ Million)
Table 15. Global Biologics Revenue by Region (2024-2029) & (US$ Million)
Table 16. Global Biologics Revenue Market Share by Region (2018-2023)
Table 17. Global Biologics Revenue Market Share by Region (2024-2029)
Table 18. Global Biologics Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 19. Global Biologics Sales by Region (2018-2023) & (K MT)
Table 20. Global Biologics Sales by Region (2024-2029) & (K MT)
Table 21. Global Biologics Sales Market Share by Region (2018-2023)
Table 22. Global Biologics Sales Market Share by Region (2024-2029)
Table 23. Global Biologics Sales by Manufacturers (2018-2023) & (K MT)
Table 24. Global Biologics Sales Share by Manufacturers (2018-2023)
Table 25. Global Biologics Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 26. Global Biologics Revenue Share by Manufacturers (2018-2023)
Table 27. Biologics Price by Manufacturers 2018-2023 (USD/MT)
Table 28. Global Key Players of Biologics, Industry Ranking, 2021 VS 2022 VS 2023
Table 29. Global Biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 30. Global Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics as of 2022)
Table 31. Global Key Manufacturers of Biologics, Manufacturing Base Distribution and Headquarters
Table 32. Global Key Manufacturers of Biologics, Product Offered and Application
Table 33. Global Key Manufacturers of Biologics, Date of Enter into This Industry
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Biologics Sales by Type (2018-2023) & (K MT)
Table 36. Global Biologics Sales by Type (2024-2029) & (K MT)
Table 37. Global Biologics Sales Share by Type (2018-2023)
Table 38. Global Biologics Sales Share by Type (2024-2029)
Table 39. Global Biologics Revenue by Type (2018-2023) & (US$ Million)
Table 40. Global Biologics Revenue by Type (2024-2029) & (US$ Million)
Table 41. Global Biologics Revenue Share by Type (2018-2023)
Table 42. Global Biologics Revenue Share by Type (2024-2029)
Table 43. Biologics Price by Type (2018-2023) & (USD/MT)
Table 44. Global Biologics Price Forecast by Type (2024-2029) & (USD/MT)
Table 45. Global Biologics Sales by Application (2018-2023) & (K MT)
Table 46. Global Biologics Sales by Application (2024-2029) & (K MT)
Table 47. Global Biologics Sales Share by Application (2018-2023)
Table 48. Global Biologics Sales Share by Application (2024-2029)
Table 49. Global Biologics Revenue by Application (2018-2023) & (US$ Million)
Table 50. Global Biologics Revenue by Application (2024-2029) & (US$ Million)
Table 51. Global Biologics Revenue Share by Application (2018-2023)
Table 52. Global Biologics Revenue Share by Application (2024-2029)
Table 53. Biologics Price by Application (2018-2023) & (USD/MT)
Table 54. Global Biologics Price Forecast by Application (2024-2029) & (USD/MT)
Table 55. US & Canada Biologics Sales by Type (2018-2023) & (K MT)
Table 56. US & Canada Biologics Sales by Type (2024-2029) & (K MT)
Table 57. US & Canada Biologics Revenue by Type (2018-2023) & (US$ Million)
Table 58. US & Canada Biologics Revenue by Type (2024-2029) & (US$ Million)
Table 59. US & Canada Biologics Sales by Application (2018-2023) & (K MT)
Table 60. US & Canada Biologics Sales by Application (2024-2029) & (K MT)
Table 61. US & Canada Biologics Revenue by Application (2018-2023) & (US$ Million)
Table 62. US & Canada Biologics Revenue by Application (2024-2029) & (US$ Million)
Table 63. US & Canada Biologics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 64. US & Canada Biologics Revenue by Country (2018-2023) & (US$ Million)
Table 65. US & Canada Biologics Revenue by Country (2024-2029) & (US$ Million)
Table 66. US & Canada Biologics Sales by Country (2018-2023) & (K MT)
Table 67. US & Canada Biologics Sales by Country (2024-2029) & (K MT)
Table 68. Europe Biologics Sales by Type (2018-2023) & (K MT)
Table 69. Europe Biologics Sales by Type (2024-2029) & (K MT)
Table 70. Europe Biologics Revenue by Type (2018-2023) & (US$ Million)
Table 71. Europe Biologics Revenue by Type (2024-2029) & (US$ Million)
Table 72. Europe Biologics Sales by Application (2018-2023) & (K MT)
Table 73. Europe Biologics Sales by Application (2024-2029) & (K MT)
Table 74. Europe Biologics Revenue by Application (2018-2023) & (US$ Million)
Table 75. Europe Biologics Revenue by Application (2024-2029) & (US$ Million)
Table 76. Europe Biologics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 77. Europe Biologics Revenue by Country (2018-2023) & (US$ Million)
Table 78. Europe Biologics Revenue by Country (2024-2029) & (US$ Million)
Table 79. Europe Biologics Sales by Country (2018-2023) & (K MT)
Table 80. Europe Biologics Sales by Country (2024-2029) & (K MT)
Table 81. China Biologics Sales by Type (2018-2023) & (K MT)
Table 82. China Biologics Sales by Type (2024-2029) & (K MT)
Table 83. China Biologics Revenue by Type (2018-2023) & (US$ Million)
Table 84. China Biologics Revenue by Type (2024-2029) & (US$ Million)
Table 85. China Biologics Sales by Application (2018-2023) & (K MT)
Table 86. China Biologics Sales by Application (2024-2029) & (K MT)
Table 87. China Biologics Revenue by Application (2018-2023) & (US$ Million)
Table 88. China Biologics Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Biologics Sales by Type (2018-2023) & (K MT)
Table 90. Asia Biologics Sales by Type (2024-2029) & (K MT)
Table 91. Asia Biologics Revenue by Type (2018-2023) & (US$ Million)
Table 92. Asia Biologics Revenue by Type (2024-2029) & (US$ Million)
Table 93. Asia Biologics Sales by Application (2018-2023) & (K MT)
Table 94. Asia Biologics Sales by Application (2024-2029) & (K MT)
Table 95. Asia Biologics Revenue by Application (2018-2023) & (US$ Million)
Table 96. Asia Biologics Revenue by Application (2024-2029) & (US$ Million)
Table 97. Asia Biologics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 98. Asia Biologics Revenue by Region (2018-2023) & (US$ Million)
Table 99. Asia Biologics Revenue by Region (2024-2029) & (US$ Million)
Table 100. Asia Biologics Sales by Region (2018-2023) & (K MT)
Table 101. Asia Biologics Sales by Region (2024-2029) & (K MT)
Table 102. Middle East, Africa and Latin America Biologics Sales by Type (2018-2023) & (K MT)
Table 103. Middle East, Africa and Latin America Biologics Sales by Type (2024-2029) & (K MT)
Table 104. Middle East, Africa and Latin America Biologics Revenue by Type (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Biologics Revenue by Type (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Biologics Sales by Application (2018-2023) & (K MT)
Table 107. Middle East, Africa and Latin America Biologics Sales by Application (2024-2029) & (K MT)
Table 108. Middle East, Africa and Latin America Biologics Revenue by Application (2018-2023) & (US$ Million)
Table 109. Middle East, Africa and Latin America Biologics Revenue by Application (2024-2029) & (US$ Million)
Table 110. Middle East, Africa and Latin America Biologics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 111. Middle East, Africa and Latin America Biologics Revenue by Country (2018-2023) & (US$ Million)
Table 112. Middle East, Africa and Latin America Biologics Revenue by Country (2024-2029) & (US$ Million)
Table 113. Middle East, Africa and Latin America Biologics Sales by Country (2018-2023) & (K MT)
Table 114. Middle East, Africa and Latin America Biologics Sales by Country (2024-2029) & (K MT)
Table 115. Eli Lilly & Company Company Information
Table 116. Eli Lilly & Company Description and Major Businesses
Table 117. Eli Lilly & Company Biologics Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 118. Eli Lilly & Company Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Eli Lilly & Company Recent Development
Table 120. Samsung Biologics Company Information
Table 121. Samsung Biologics Description and Major Businesses
Table 122. Samsung Biologics Biologics Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 123. Samsung Biologics Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Samsung Biologics Recent Development
Table 125. F Hoffman La Roche Company Information
Table 126. F Hoffman La Roche Description and Major Businesses
Table 127. F Hoffman La Roche Biologics Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 128. F Hoffman La Roche Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. F Hoffman La Roche Recent Development
Table 130. Celltrion Company Information
Table 131. Celltrion Description and Major Businesses
Table 132. Celltrion Biologics Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 133. Celltrion Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Celltrion Recent Development
Table 135. Addgene Company Information
Table 136. Addgene Description and Major Businesses
Table 137. Addgene Biologics Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 138. Addgene Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Addgene Recent Development
Table 140. Amgen Company Information
Table 141. Amgen Description and Major Businesses
Table 142. Amgen Biologics Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 143. Amgen Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Amgen Recent Development
Table 145. Abbvie Inc. Company Information
Table 146. Abbvie Inc. Description and Major Businesses
Table 147. Abbvie Inc. Biologics Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 148. Abbvie Inc. Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Abbvie Inc. Recent Development
Table 150. Sanofi Company Information
Table 151. Sanofi Description and Major Businesses
Table 152. Sanofi Biologics Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 153. Sanofi Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Sanofi Recent Development
Table 155. Pfizer Inc. Company Information
Table 156. Pfizer Inc. Description and Major Businesses
Table 157. Pfizer Inc. Biologics Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 158. Pfizer Inc. Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Pfizer Inc. Recent Development
Table 160. Merck & Co. Inc. Company Information
Table 161. Merck & Co. Inc. Description and Major Businesses
Table 162. Merck & Co. Inc. Biologics Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 163. Merck & Co. Inc. Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Merck & Co. Inc. Recent Development
Table 165. Novo Nordisk A/S Company Information
Table 166. Novo Nordisk A/S Description and Major Businesses
Table 167. Novo Nordisk A/S Biologics Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 168. Novo Nordisk A/S Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Novo Nordisk A/S Recent Development
Table 170. Johnson & Johnson Services Inc. Company Information
Table 171. Johnson & Johnson Services Inc. Description and Major Businesses
Table 172. Johnson & Johnson Services Inc. Biologics Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 173. Johnson & Johnson Services Inc. Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Johnson & Johnson Services Inc. Recent Development
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Biologics Distributors List
Table 178. Biologics Customers List
Table 179. Biologics Market Trends
Table 180. Biologics Market Drivers
Table 181. Biologics Market Challenges
Table 182. Biologics Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Biologics Product Picture
Figure 2. Global Biologics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Biologics Market Share by Type in 2022 & 2029
Figure 4. Monoclonal Antibodies Product Picture
Figure 5. Vaccines Product Picture
Figure 6. Recombinant Proteins Product Picture
Figure 7. Antisense Product Picture
Figure 8. RNAi Product Picture
Figure 9. Global Biologics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global Biologics Market Share by Application in 2022 & 2029
Figure 11. Infectious Diseases
Figure 12. Oncology
Figure 13. Immunology
Figure 14. Autoimmune Diseases
Figure 15. Biologics Report Years Considered
Figure 16. Global Biologics Capacity, Production and Utilization (2018-2029) & (K MT)
Figure 17. Global Biologics Production Market Share by Region in Percentage: 2022 Versus 2029
Figure 18. Global Biologics Production Market Share by Region (2018-2029)
Figure 19. Biologics Production Growth Rate in North America (2018-2029) & (K MT)
Figure 20. Biologics Production Growth Rate in Europe (2018-2029) & (K MT)
Figure 21. Biologics Production Growth Rate in China (2018-2029) & (K MT)
Figure 22. Biologics Production Growth Rate in Japan (2018-2029) & (K MT)
Figure 23. Global Biologics Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 24. Global Biologics Revenue 2018-2029 (US$ Million)
Figure 25. Global Biologics Revenue (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Figure 26. Global Biologics Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 27. Global Biologics Revenue Market Share by Region (2018-2029)
Figure 28. Global Biologics Sales 2018-2029 ((K MT)
Figure 29. Global Biologics Sales (CAGR) by Region: 2018 VS 2022 VS 2029 (K MT)
Figure 30. Global Biologics Sales Market Share by Region (2018-2029)
Figure 31. US & Canada Biologics Sales YoY (2018-2029) & (K MT)
Figure 32. US & Canada Biologics Revenue YoY (2018-2029) & (US$ Million)
Figure 33. Europe Biologics Sales YoY (2018-2029) & (K MT)
Figure 34. Europe Biologics Revenue YoY (2018-2029) & (US$ Million)
Figure 35. China Biologics Sales YoY (2018-2029) & (K MT)
Figure 36. China Biologics Revenue YoY (2018-2029) & (US$ Million)
Figure 37. Asia (excluding China) Biologics Sales YoY (2018-2029) & (K MT)
Figure 38. Asia (excluding China) Biologics Revenue YoY (2018-2029) & (US$ Million)
Figure 39. Middle East, Africa and Latin America Biologics Sales YoY (2018-2029) & (K MT)
Figure 40. Middle East, Africa and Latin America Biologics Revenue YoY (2018-2029) & (US$ Million)
Figure 41. The Biologics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 42. The Top 5 and 10 Largest Manufacturers of Biologics in the World: Market Share by Biologics Revenue in 2022
Figure 43. Global Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 44. Global Biologics Sales Market Share by Type (2018-2029)
Figure 45. Global Biologics Revenue Market Share by Type (2018-2029)
Figure 46. Global Biologics Sales Market Share by Application (2018-2029)
Figure 47. Global Biologics Revenue Market Share by Application (2018-2029)
Figure 48. US & Canada Biologics Sales Market Share by Type (2018-2029)
Figure 49. US & Canada Biologics Revenue Market Share by Type (2018-2029)
Figure 50. US & Canada Biologics Sales Market Share by Application (2018-2029)
Figure 51. US & Canada Biologics Revenue Market Share by Application (2018-2029)
Figure 52. US & Canada Biologics Revenue Share by Country (2018-2029)
Figure 53. US & Canada Biologics Sales Share by Country (2018-2029)
Figure 54. U.S. Biologics Revenue (2018-2029) & (US$ Million)
Figure 55. Canada Biologics Revenue (2018-2029) & (US$ Million)
Figure 56. Europe Biologics Sales Market Share by Type (2018-2029)
Figure 57. Europe Biologics Revenue Market Share by Type (2018-2029)
Figure 58. Europe Biologics Sales Market Share by Application (2018-2029)
Figure 59. Europe Biologics Revenue Market Share by Application (2018-2029)
Figure 60. Europe Biologics Revenue Share by Country (2018-2029)
Figure 61. Europe Biologics Sales Share by Country (2018-2029)
Figure 62. Germany Biologics Revenue (2018-2029) & (US$ Million)
Figure 63. France Biologics Revenue (2018-2029) & (US$ Million

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nucleotide Professional Survey Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 132

Nucleotides are organic molecules consisting of a nucleoside and a phosphate. They serve as monomeric units of the nucleic acid polymers deoxyribonucleic acid and ribonucleic acid, both of which are essential biomolecules within all life-forms on Earth. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This wa......

Global Nucleotide Market Research Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 165

Nucleotides are organic molecules consisting of a nucleoside and a phosphate. They serve as monomeric units of the nucleic acid polymers deoxyribonucleic acid and ribonucleic acid, both of which are essential biomolecules within all life-forms on Earth. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This wa......

Global Bioburden Testing Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 120

Report Overview: The Global Bioburden Testing Market Size was estimated at USD 898.90 million in 2022 and is projected to reach USD 1443.44 million by 2029, exhibiting a CAGR of 7.00% during the forecast period. This report provides a deep insight into the global Bioburden Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market dri......

Global qPCR Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Nov-2023        Price: US 3380 Onwards        Pages: 126

Market Overview of Global qPCR market: According to our latest research, the global qPCR market looks promising in the next 5 years. As of 2022, the global qPCR market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global qPCR market, with a systematical description of the status ......

Global Interferon Market Research Report 2023, Forecast to 2028

Published: 01-Nov-2023        Price: US 2680 Onwards        Pages: 131

Interferons are proteins that are part of your natural defenses. They tell your immune system that germs or cancer cells are in your body. And they trigger killer immune cells to fight those invaders. Interferons got their name because they "interfere" with viruses and keep them from multiplying. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) dat......

Global Interferon Professional Survey Report 2023, Forecast to 2028

Published: 01-Nov-2023        Price: US 3280 Onwards        Pages: 107

Interferons are proteins that are part of your natural defenses. They tell your immune system that germs or cancer cells are in your body. And they trigger killer immune cells to fight those invaders. Interferons got their name because they "interfere" with viruses and keep them from multiplying. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) dat......

Global Biologics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Oct-2023        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Biologics market: According to our latest research, the global Biologics market looks promising in the next 5 years. As of 2022, the global Biologics market was estimated at USD 251622.83 million, and it's anticipated to reach USD 363588.32 million in 2028, with a CAGR of 6.33% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Biologics market, with a sys......

Global Nucleotide Market Insights, Forecast to 2029

Published: 25-Sep-2023        Price: US 4900 Onwards        Pages: 89

Nucleotides are small organic molecules composed of purine bases or pyrimidine bases, pentoses and phosphoric acid. They are the structural units of nucleic acids, and their derivatives have a variety of biological functions. It can be used in the fields of food, pharmaceuticals and feed additive. The global Nucleotide market is projected to grow from US$ 511.1 million in 2023 to US$ 492.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of -0.6% during the forecast period. ......

2023-2031 Report on Global Nucleotide Market by Player, Region, Type, Application and Sales Channel

Published: 04-Sep-2023        Price: US 2500 Onwards        Pages: 89

This report studies the Nucleotide market, covering market size for segment by type (Food Grade Nucleotide, Lab Grade Nucleotide, etc.), by application (Pharmaceuticals, Food & Beverage Additives, etc.), by sales channel (Direct Channel, Distribution Channel), by player (AJINOMOTO, CJ, DAESANG, Meihua Group, Star Lake Bioscience, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of g......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs